Cargando…
_version_ 1785028406410215424
author Gil Mosquera, Manuel
Fernández-Ruiz, Mario
author_facet Gil Mosquera, Manuel
Fernández-Ruiz, Mario
author_sort Gil Mosquera, Manuel
collection PubMed
description
format Online
Article
Text
id pubmed-10116356
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Elsevier España, S.L.U.
record_format MEDLINE/PubMed
spelling pubmed-101163562023-04-20 Reply Gil Mosquera, Manuel Fernández-Ruiz, Mario Med Clin (Engl Ed) Letter to the Editor Elsevier España, S.L.U. 2023-05-12 2023-04-20 /pmc/articles/PMC10116356/ /pubmed/37168523 http://dx.doi.org/10.1016/j.medcle.2022.12.008 Text en © 2022 Elsevier España, S.L.U. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Letter to the Editor
Gil Mosquera, Manuel
Fernández-Ruiz, Mario
Reply
title Reply
title_full Reply
title_fullStr Reply
title_full_unstemmed Reply
title_short Reply
title_sort reply
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10116356/
https://www.ncbi.nlm.nih.gov/pubmed/37168523
http://dx.doi.org/10.1016/j.medcle.2022.12.008
work_keys_str_mv AT gilmosqueramanuel reply
AT fernandezruizmario reply